Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Takahashi R, Yamamoto K, Toya H, Shoji H, et al. A selective RPL15 PROTAC degrader enhances anti-PD-1 immunotherapy in a murine melanoma tumor model. Oncogene 2025 Nov 23. doi: 10.1038/s41388-025-03641.
PMID: 41276688


Privacy Policy